The short version of circadian clock fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2025-11-14. Anything still debated is marked as such rather than presented as settled.
REV-ERB proteins help regulate daily cycles in gene expression, including genes tied to lipid and glucose metabolism. SR9009 binds these receptors and alters their activity in cell and animal experiments. Consequences observed in rodents include changes in skeletal muscle oxidative capacity, blood lipid levels, and exercise performance. The precise chain from receptor occupancy to whole-body effects is still an active area of study. Human responses cannot be assumed from rodent data.
Most published work on SR9009 consists of preclinical studies. It is widely sold as a research chemical, a category that does not imply safety, efficacy, or pharmaceutical-grade quality. Sports anti-doping organizations have listed SR9009 as a prohibited substance, and its presence in an athlete sample can lead to sanctions. Legal status differs by country; in several jurisdictions it is not approved for human consumption and may be treated as an unapproved new drug.
Handling recommendations for SR9009 in a laboratory setting include storing the solid at low temperature, protected from light and moisture. The compound is often dissolved in dimethyl sulfoxide or ethanol for experiments. Solutions should be prepared with appropriate personal protective equipment and disposed of according to local rules. Stability data for long-term storage are limited, so stock solutions are typically kept cold and used within defined periods. Records of preparation date and concentration support reproducibility.
SR9009 is not approved as a medicine by major regulatory agencies. It is commonly sold as a research chemical, a category that may fall outside customary drug approval and quality rules. In sports, the World Anti-Doping Agency lists SR9009 as a prohibited substance. Athletes who use it can face sanctions if it is detected in a sample. Legal status varies by country, and importation may be restricted. Enforcement practices differ across borders.
Detection of SR9009 in biological samples usually employs liquid chromatography coupled with tandem mass spectrometry. This method can identify the parent compound and sometimes metabolites in urine or blood. Because exposure can be low and clearance may be rapid, sample timing and limits of detection matter. Laboratories validate assays for sensitivity and specificity. Results are interpreted alongside chain-of-custody and quality-control records. Urine is the common matrix for anti-doping analysis, while blood may be used in research settings.
| Property | Value | Notes |
|---|---|---|
| Common name | SR9009 | Also referred to as Stenabolic in non-scientific contexts. |
| Chemical class | Synthetic small molecule | Not a steroid or peptide hormone. |
| Receptor target | REV-ERBα and REV-ERBβ | Nuclear receptor agonist in preclinical studies. |
| Development status | Investigational | No approved human therapeutic indication. |
| Regulatory attention | Prohibited in sport | Listed by anti-doping authorities. |
Mechanistically, SR9009 binds the ligand-binding domain of REV-ERBα/β and enhances recruitment of corepressor complexes. This represses target genes rather than activating them. Because REV-ERB proteins normally compete with ROR proteins at shared response elements, the net effect depends on tissue and timing. Researchers use SR9009 to probe how nuclear receptor signaling links the clock to metabolism, inflammation, and muscle biology. Findings are largely preclinical, and the precise contribution of each receptor subtype remains under study.
SR9009 is frequently discussed in fitness and research-chemical contexts, yet it has no approved medical indication. Regulatory agencies have not authorized it for human use, and it is not a standard prescription drug. Some sports organizations list it as a prohibited substance because of its potential performance-enhancing properties. Published human data are sparse, so claims about its effects in people often rely on animal models or anecdotal reports. Quality and identity of online materials can vary widely.
Laboratory samples of SR9009 are typically supplied as a white to off-white powder. The compound dissolves readily in organic solvents such as dimethyl sulfoxide and ethanol, while its solubility in water is low. Because of this solubility profile, researchers often prepare concentrated stock solutions in an organic solvent before diluting them into aqueous assay buffers. Light exposure, moisture, and repeated freeze-thaw cycles can degrade many small molecules, so handling procedures usually aim to minimize these factors. Purity is commonly checked before use.
Storage conditions for research-grade SR9009 generally involve a freezer at approximately minus twenty degrees Celsius, sometimes lower for long-term preservation. Containers should remain tightly closed and protected from light. Desiccants may be used to limit moisture uptake. Solutions are often stored in aliquots to avoid repeated warming and cooling. Stability data for the compound under various conditions are limited, so laboratories typically follow supplier recommendations and verify performance through periodic analytical checks rather than assuming indefinite stability.
Following a decentralized strategy, Iranian units responded with a series of missile and drone attacks against Israel and US military bases in the Middle East, attacked US allies in the Middle East, as well as blocked the Strait of Hormuz and subsequently claimed sovereignty over it in late March. Following the strikes on their territory, the United Arab Emirates, Saudi Arabia, Kuwait, and Bahrain also attacked Iran and skirmished with its Iraqi non-state allies. Two days after Khamenei's assassination, fighting resumed between Hezbollah and Israel. Israel began occupying southern Lebanon in March. An escalation of the Yemeni civil war by the Iran-backed Houthi forces in September started the Strait of Bab al-Mandab crisis. The war has resulted in thousands of civilian and military casualties. The economic impact of the war included the largest supply disruption of the global oil market, disruptions of the natural gas, fertilizer, aviation, and tourism industries, and volatility in financial markets. As of September 2026, the US Department of Defense estimated that the war had so far cost $43.6 billion. The secretary-general of the United Nations and several countries condemned the US–Israeli strikes, while the United Nations Security Council passed a resolution condemning Iran's retaliatory strikes on Gulf states. A two-week ceasefire beginning on 8 April came under strain after Iran responded to Israeli attacks on Lebanon by resuming its blockade. After the failure of the Islamabad Talks on 12–13 April, the US imposed its own naval blockade.
Drew went to New York City as the medical director of the United States' Blood for Britain project, a project to aid British soldiers and civilians by giving U.S. blood to the United Kingdom. It was here that Drew helped set the standard for other hospitals donating blood plasma to Britain by ensuring clean transfusions along with proper aseptic technique to ensure viable plasma dispersals were sent to Britain. Drew created a central location for the blood collection process where donors could go to give blood. He made sure all blood plasma was tested before it was shipped out. He ensured that only skilled personnel handled blood plasma to avoid the possibility of contamination. The Blood for Britain program operated successfully for five months, with total collections of almost 15,000 people donating blood, and with over 5,500 vials of blood plasma.
=== Provincial government === Yasir Naqvi, the Attorney General of Ontario, and Eric Hoskins, the province's Minister of Health and Long-Term Care, jointly announced on the day of Wettlaufer's sentencing that the provincial government would commission a public inquiry into her case. The full details of the inquiry were not given in the announcement, as the government had yet to determine the scope or an individual to lead the inquiry, with Naqvi and Hoskins instead saying that the inquiry would "get the answers we need to help ensure a tragedy such as this does not happen again." The delay in establishing the inquiry was criticized by members of the opposition Progressive Conservative and New Democratic parties toward the end of July 2017, as no progress had seemingly been made since the announcement and the Legislative Assembly had risen for its summer recess. The Public Inquiry into the Safety and Security of Residents in the Long-Term Care Homes System was formally established by the provincial government on August 1, 2017. Justice Eileen Gillese of the Court of Appeal for Ontario was appointed commissioner of the inquiry. The inquiry was to include interviews with victims' families and public consultations in the community as it investigated the circumstances surrounding the deaths of Wettlaufer's victims and gaps in legislative or policy frameworks that allowed her to continue working as a nurse. The inquiry's lead counsel stated that "anyone from Wettlaufer to Premier Kathleen Wynne" may be called to testify before the inquiry based on the evidence that is uncovered.
While EU law has not yet developed a civil code for contracts, torts, unjust enrichment, real or personal property, or commerce in general, European legal scholars have drafted common principles, including Principles of European Contract Law and Principles of European Tort Law that are common to member states. In absence of harmonisation, there is a comprehensive system of conflicts of laws to settle the jurisdiction of courts, and the applicable law, for most commercial disputes. The Brussels I Regulation 2012 determines the jurisdiction of courts depending upon where a person is domiciled or has operations. The applicable law for consensual obligations is then determined by the Rome I Regulation, where article 3 states the principle that a choice of law can be made expressly in a contract, unless this affects provisions that cannot be derogated from, such as employment, consumer, tenancy or other rights. The Rome II Regulation determines applicable law in the case of non-consensual obligations, such as torts and unjust enrichment. Under article 4 the general rule is that the law applies where "the damage occurred", although under article 7 in the case of "environmental damage or damage sustained by persons or property as a result" there is a choice to bring an action under the law of the tortfeasor. Unlike other property forms, intellectual property rights are comprehensively regulated by a series of directives on copyrights, patents and trademarks.
== External links == Histology image: 14805loa – Histology Learning System at Boston University Anatomy photo: Reproductive/mammal/ovary2/ovary5 - Comparative Organology at University of California, Davis - "Mammal, canine ovary (LM, High)" Anatomy photo: Reproductive/mammal/ovary5/ovary6 - Comparative Organology at University of California, Davis - "Mammal, bovine ovary (LM, Medium)" Anatomy Atlases – Microscopic Anatomy, plate 13.249 Slide at trinity.edu
Sources: en.wikipedia.org
=== Physicochemical === PAHs are nonpolar and lipophilic. Larger PAHs are generally insoluble in water, although some smaller PAHs are soluble. The larger members are also poorly soluble in organic solvents and in lipids. The larger members, such as perylene, are strongly colored.
=== Sex organs === Hydrostatic penises have convergently evolved at least six times in male amniotes. In these species, males copulate with females and internally fertilize their eggs. Similar intromittent organs have evolved in invertebrates such as octopuses and gastropods.
== Early life and education == Delibegovic is from Tuzla in Bosnia and Herzegovina. She grew up during the Bosnian War, which forced her family apart. In the early nineties, she moved to Scotland and finished her secondary school education at George Heriot's School in Edinburgh. Delibegovic studied pharmacology at the University of Edinburgh. In the final year of her undergraduate degree Delibegovic moved to Essex, where she did her undergraduate final year project at GlaxoSmithKline on novel anti-diabetes drugs. She completed her doctoral research with Prof Dame Patricia Cohen at the University of Dundee Medical Research Council Protein Phosphorylation Unit. Here she studied the way that enzymes such as protein phosphatase 1 influenced diabetes development. She was supported by the Royal Society studentship. She has said that she was interested in diabetes because of family history and prevalence of Type 2 diabetes in Bosnia and Herzegovina. During her doctoral research, Delibegovic worked closely with pharmaceutical companies to translate her research to the read world. In 2003 she was awarded the American Heart Association personal fellowship to study the role of PTPN1 in glucose homeostasis at the Harvard Medical School in Boston, USA. She spent four years in Boston, working with Prof Benjamin Neel on mouse models of insulin resistance.
== Alternative sources == Because of the limited availability of mammalian stomachs for rennet production, cheese makers have sought other ways to coagulate milk since at least Roman times. The many sources of enzymes that can be a substitute for animal rennet range from plants and fungi to microbial sources. Cheeses produced from any of these varieties of rennet are suitable for lactovegetarians, as well as those keeping Kosher. Fermentation-produced chymosin is used more often in industrial cheesemaking in North America and Europe today because it is less expensive than animal rennet.
Sources: en.wikipedia.org
For services to Higher Education. Carol Stump. Lately, President, Libraries Connected. For services to Public Libraries. Jacqueline Penelope Suttie. Founder and Chief Executive Officer, PTSD UK. For services to People with Post Traumatic Stress Disorder. Christopher Bennet Symonds. Senior Doorkeeper, House of Commons. For services to Parliament. Bolanle Tajudeen. Founder and Director, Bolanle Contemporary and Founder and Director, Black Blossoms. For services to the Arts. Deborah Janine Tann. Chief Executive, Hampshire and Isle of Wight Wildlife Trust. For services to Wildlife and the Natural Environment. Dr. Muhammad Saleem Khan Tareen. Psychiatrist, Northern Health and Social Care Trust. For services to Mental Ill Health and to Community Development in Northern Ireland. Jenny Thompson. Co-Founder and Director, Market Operations. For services to the Business and Food Sectors. Laurence Joseph Thraves. Head, National Situation Centre, Cabinet Office. For Public Service. Troy Donoghue Townsend. Head of Player Engagement, Kick It Out. For services to Diversity and Inclusion in Association Football. Deborah Ann Turnbull. Founder and Director, River and Sea Sense. For services to Water Safety Education for Young People and Families. Steven Underwood. Lately Mathematics Teacher, Ryedale School, Beadlam, North Yorkshire. For services to Education. Robin Arden Varley. Chair, Cricket Wales North Area Board, Cricket Wales Ltd. For services to Cricket in Wales. Sarah Vaughan. Deputy Head Teacher, Perryfields Primary Pupil Referral Unit, Worcester. For services to Education.
== Etymology and naming == The most common English names for the species include great white shark, white shark, and the Australian English variant white pointer. These names refer to its white underside, which is noticeable in dead sharks lying upside down. Colloquial use favors the name 'great white shark' or simply 'great white', with 'great' perhaps emphasizing the size and power of the species. Scientists typically use 'white shark' or 'the white shark' as no "lesser white shark" exists for comparison, though some use 'white shark' to refer to all members of the Lamnidae. The scientific generic name, Carcharodon, combines two Greek words. The prefix carchar- is derived from κάρχαρος (kárkharos), which means "sharp". The suffix -odon derives from ὀδών (odṓn), which translates to "tooth". The specific name carcharias is from the καρχαρίας (karkharías), the Ancient Greek word for shark. The white shark was one of the species originally described by Carl Linnaeus in his 1758 10th edition of Systema Naturae and assigned the scientific name Squalus carcharias, Squalus being the genus in which he placed all sharks. By the 1810s, the shark was recognized as needing to be placed in a new genus, but not until 1838 did Sir Andrew Smith coin the name Carcharodon as the new genus. A few attempts have been made to describe and classify the white shark before Linnaeus. One of the earliest mentions of it in literature as a distinct type of animal appears in a 1553 book by Pierre Belon.
The same property causes ultraviolet sunlight to dissociate volatile organobromine compounds in the atmosphere to yield free bromine atoms, causing ozone depletion. As a result, some organobromine compounds—such as the pesticide methyl bromide—are no longer used. Bromine compounds are still used in well drilling fluids, in photographic film, and as an intermediate in the manufacture of organic chemicals. Large amounts of bromide salts are toxic from the action of soluble bromide ions, causing bromism. However, bromine is beneficial for human eosinophils, and is an essential trace element for collagen development in all animals. Hundreds of known organobromine compounds are generated by terrestrial and marine plants and animals, and some serve important biological roles. As a pharmaceutical, the simple bromide ion (Br−) has inhibitory effects on the central nervous system, and bromide salts were once a major medical sedative, before replacement by shorter-acting drugs. They retain niche uses as antiepileptics.
Sources: en.wikipedia.org
It is a synthetic compound studied as an agonist of REV-ERB nuclear receptors. It is not an approved medicine and has mainly been examined in laboratory and animal research.
No. It is a small molecule that binds nuclear receptors involved in circadian regulation. Its classification differs from anabolic steroids or peptide hormones.
Published human clinical trial data are lacking. Most safety and activity information comes from preclinical models, so effects in people remain uncertain.
Its legal status depends on the country and intended use. It is not an approved medicine in major jurisdictions. In sport, it is prohibited by anti-doping rules.